Caris
Caris Life Sciences, Pramana Ink Slide Digitization Deal
Under the deal, Pramana will scan about 1.5 million pathology slide specimens per year in support of Caris' digital pathology business.
Companies that built their business in tissue and blood-based DNA analyses are now exploring imaging technologies across a variety of fronts.
Caris Life Sciences Raises $400M in Senior Secured Debt Financing
The company said it will use the proceeds to repay outstanding debt and enhance its precision medicine platform, in addition to funding general corporate activities.
Caris Life Sciences Taps Juniper Biologics to Market Sequencing Tests in Southeast Asia
The move will make Caris' comprehensive cancer sequencing services available to physicians and patients in the region.
Caris Life Sciences Adds Everything Genetic as UK Distributor
Everything Genetic will distribute Caris Life Sciences' Molecular Intelligence Tumor Seek NGS-based tumor profiling service in the UK.
Sep 7, 2022
May 19, 2021